Main > ONCOLOGY (**) > Leukemia>Hairy Cell Leukemia>R/R*> > TREAT.: > Co: UK. A. MoxetumoMAb Pasudotox
Co: UK. A. MoxetumoMAb Pasudotox's subsections
(*) USA Approval Date: 2018. 09.13
>2 Prior Systemic Therapies>
Company
Pasudotox:
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2018. 09.11.
TradeMark
TradeMark Web-Site
Co: UK. A. MoxetumoMAb Pasudotox's products
This section has no products